PapersFlow Research Brief
Lymphatic System and Diseases
Research Guide
What is Lymphatic System and Diseases?
The lymphatic system and diseases refer to the network of lymphatic vessels, nodes, and organs that maintain fluid balance, facilitate immune responses, and are implicated in pathological conditions such as cancer metastasis through lymphangiogenesis involving VEGF-C, tumor lymphatics, macrophages, podoplanin, and VEGFR-3 signaling, as well as lymphedema and inflammation.
This field encompasses 36,148 papers on molecular mechanisms of lymphangiogenesis in cancer metastasis and lymphatic vascular development. Key components include VEGF-C, VEGFR-3 signaling, podoplanin expression on lymphatic endothelial cells, and roles of macrophages and tumor lymphatics. Growth rate over the past 5 years is not available in the data.
Topic Hierarchy
Research Sub-Topics
VEGF-C signaling in lymphangiogenesis
This sub-topic dissects the VEGFR-3 receptor activation, downstream pathways, and lymphatic endothelial cell proliferation induced by VEGF-C. Researchers study ligand processing and therapeutic modulation.
Tumor lymphatics and cancer metastasis
Examines lymphatic vessel density, intravasation sites, and sentinel lymph node involvement in solid tumors. Studies correlate lymphatic markers with metastatic prognosis.
Podoplanin expression in lymphatic endothelium
Focuses on podoplanin as a lymphatic marker, its role in endothelial cell migration, and platelet interactions. Research explores diagnostic utility and therapeutic antibodies.
Macrophages in lymphangiogenesis regulation
Investigates macrophage VEGF-C production, lymphatic sprouting induction, and tissue remodeling during inflammation and tumorigenesis. Single-cell analyses reveal polarization states.
Lymphedema molecular pathogenesis
This area covers lymphatic valve dysfunction, collecting vessel pumping failure, and chronic inflammation in genetic and post-surgical lymphedema. Studies test growth factor therapies.
Why It Matters
Lymphangiogenesis enables cancer metastasis via lymphatic vessels, with VEGF-C and VEGFR-3 signaling promoting tumor lymphatics, as explored in vascular signaling papers. For instance, Olsson et al. (2006) in "VEGF receptor signalling – in control of vascular function" detail how VEGFR-3 regulates lymphatic endothelial cell function critical for metastasis spread. These insights support therapeutic targeting in oncology, where disruptions lead to lymphedema post-cancer treatment, affecting patient quality of life. Apte et al. (2019) in "VEGF in Signaling and Disease: Beyond Discovery and Development" highlight VEGF pathway inhibitors' applications in reducing pathological angiogenesis and lymphangiogenesis in cancers.
Reading Guide
Where to Start
"VEGF receptor signalling – in control of vascular function" by Olsson et al. (2006) provides a foundational overview of VEGFR-3 signaling in lymphatic development, directly relevant to lymphangiogenesis in cancer.
Key Papers Explained
Olsson et al. (2006) in "VEGF receptor signalling – in control of vascular function" (3042 citations) establishes VEGFR-3 control of lymphangiogenesis, building on Fong et al. (1995) "Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium" (2612 citations) which covers related endothelial assembly via VEGF receptors. Apte et al. (2019) "VEGF in Signaling and Disease: Beyond Discovery and Development" (2556 citations) extends these to disease applications including lymphatic pathologies. Suri et al. (1996) "Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis" (2838 citations) connects angiopoietin pathways to lymphatic vascular stability.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current frontiers involve unresolved roles of podoplanin and macrophages in tumor lymphatics, based on the cluster's emphasis without recent preprints. Focus persists on VEGF-C/VEGFR-3 in metastasis models from foundational papers like Olsson et al. (2006).
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Asso... | 2001 | The Journal of Clinica... | 3.4K | ✓ |
| 2 | Circulating Endothelial Progenitor Cells, Vascular Function, a... | 2003 | New England Journal of... | 3.4K | ✕ |
| 3 | VEGF receptor signalling ? in control of vascular function | 2006 | Nature Reviews Molecul... | 3.0K | ✕ |
| 4 | Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Recept... | 1996 | Cell | 2.8K | ✓ |
| 5 | American College of Sports Medicine Roundtable on Exercise Gui... | 2010 | Medicine & Science in ... | 2.7K | ✓ |
| 6 | Role of the Flt-1 receptor tyrosine kinase in regulating the a... | 1995 | Nature | 2.6K | ✕ |
| 7 | Pericytes: Developmental, Physiological, and Pathological Pers... | 2011 | Developmental Cell | 2.6K | ✓ |
| 8 | VEGF in Signaling and Disease: Beyond Discovery and Development | 2019 | Cell | 2.6K | ✓ |
| 9 | Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an... | 1998 | Cell | 2.5K | ✓ |
| 10 | Endothelial Progenitor Cells | 2004 | Circulation Research | 2.3K | ✕ |
Frequently Asked Questions
What role does VEGF-C play in lymphatic system diseases?
VEGF-C drives lymphangiogenesis essential for cancer metastasis by activating VEGFR-3 on lymphatic endothelial cells. This process expands tumor lymphatics, facilitating tumor cell spread. Inhibition of VEGF-C signaling represents a strategy to block lymphatic metastasis.
How do tumor lymphatics contribute to cancer metastasis?
Tumor lymphatics provide routes for cancer cells to disseminate from primary tumors to lymph nodes and distant sites. Macrophages within tumors express VEGF-C, stimulating lymphatic vessel growth. Podoplanin marks these lymphatic endothelial cells involved in metastasis.
What is the function of VEGFR-3 signaling in lymphangiogenesis?
VEGFR-3 signaling mediates VEGF-C effects on lymphatic endothelial cell proliferation and migration during vessel formation. Olsson et al. (2006) showed VEGFR-3 controls vascular permeability and integrity in lymphatics. Dysregulation promotes pathological lymphangiogenesis in cancer.
What are the main methods studied for lymphatic diseases?
Studies focus on molecular pathways like VEGF-C/VEGFR-3 and podoplanin expression in lymphatic endothelial cells. Macrophage contributions to lymphangiogenesis are analyzed via genetic models and inhibitors. Lymphedema models assess inflammation's impact on lymphatic function.
What is the current state of lymphatic system research in oncology?
Research centers on 36,148 works examining lymphangiogenesis in metastasis, with emphasis on VEGF-C, tumor lymphatics, and VEGFR-3. Key papers like "VEGF receptor signalling – in control of vascular function" (2006, 3042 citations) establish signaling basics. No recent preprints or news indicate steady foundational progress.
Open Research Questions
- ? How can VEGF-C/VEGFR-3 inhibitors specifically block tumor lymphangiogenesis without disrupting normal lymphatic function?
- ? What is the precise role of macrophages and podoplanin in initiating lymphatic vessel sprouting in tumors?
- ? How does inflammation alter VEGFR-3 signaling to exacerbate lymphedema in cancer patients?
- ? Which molecular markers best predict lymphatic metastasis risk across cancer types?
- ? Can targeting tumor lymphatics improve immunotherapy outcomes in metastatic disease?
Recent Trends
The field maintains 36,148 papers with no specified 5-year growth rate.
Highly cited works like "VEGF receptor signalling – in control of vascular function" (Olsson et al., 2006, 3042 citations) and "VEGF in Signaling and Disease: Beyond Discovery and Development" (Apte et al., 2019, 2556 citations) underscore sustained focus on VEGF pathways in lymphangiogenesis.
No recent preprints or news coverage available indicate stable research momentum.
Research Lymphatic System and Diseases with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Lymphatic System and Diseases with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers